Alpha Lipoic Acid: 40 mg
A method of reversing, ameliroating or slowing progression of at least one symptom of Parkinson's disease in a patient in need thereof, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to reverse, ameliorate or slow progression of said at least one symptom of Parkinson's disease, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 wherein Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
External resources NCBI StatPearls: Topiramate and Phentermine clinical reference STEP 1 trial extension: Weight regain after semaglutide withdrawal NEJM: Once-weekly semaglutide in adults with overweight or obesity Comparative effectiveness systematic review of semaglutide, liraglutide, orlistat, and phentermine In case I do not see you, good afternoon, good evening, and good night
No serious TEAEs, TEAEs leading to study withdrawal or deaths were reported
Dhillon, A.S., et al., MAP kinase signalling pathways in cancer
